The Leadership Team at Stuart Therapeutics drives the strategic direction and vision of the company, overseeing research, clinical development, and program management for the PolyCol platform. Comprising experts in science, medicine, and business, the team collaborates to ensure the effective advancement of innovative ophthalmic therapies, aligning operational goals with regulatory compliance and market needs.
View all